CHUIKYO: molecules with a published decision record
78 molecules on this site carry at least one CHUIKYO decision. Each page compares that decision with every other agency that assessed the same molecule.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| upadacitinib | 93 | 16 | Immunosuppressants |
| trastuzumab deruxtecan | 64 | 14 | Antineoplastics |
| zanubrutinib | 58 | 16 | Antineoplastics |
| cabozantinib | 56 | 15 | Antineoplastics |
| bimekizumab | 55 | 14 | Immunosuppressants |
| ravulizumab | 54 | 15 | Immunosuppressants |
| selpercatinib | 53 | 13 | Antineoplastics |
| semaglutide | 53 | 14 | Diabetes |
| acalabrutinib | 52 | 14 | Antineoplastics |
| niraparib | 42 | 15 | Antineoplastics |
| darolutamide | 38 | 15 | Endocrine therapy |
| isatuximab | 38 | 12 | Antineoplastics |
| tisagenlecleucel | 37 | 12 | Antineoplastics |
| melatonin | 35 | 8 | Psycholeptics |
| axicabtagene ciloleucel | 34 | 12 | Antineoplastics |
| pegcetacoplan | 33 | 16 | Ophthalmologicals |
| sacituzumab govitecan | 31 | 15 | Antineoplastics |
| larotrectinib | 29 | 14 | Antineoplastics |
| lisocabtagene maraleucel | 27 | 11 | Antineoplastics |
| vutrisiran | 27 | 15 | Other nervous system |
| filgotinib | 26 | 13 | Immunosuppressants |
| brigatinib | 25 | 14 | Antineoplastics |
| talazoparib | 25 | 13 | Antineoplastics |
| teduglutide | 25 | 12 | Other alimentary tract and metabolism |
| odevixibat | 24 | 13 | Bile and liver therapy |
| posaconazole | 24 | 7 | Antimycotics |
| tezepelumab | 24 | 13 | Obstructive airway diseases |
| tirzepatide | 24 | 12 | Diabetes |
| epcoritamab | 23 | 14 | Antineoplastics |
| polatuzumab vedotin | 23 | 13 | Antineoplastics |
| luspatercept | 22 | 9 | Antianemics |
| abrocitinib | 21 | 13 | Other dermatologicals |
| erenumab | 21 | 13 | Analgesics |
| finerenone | 21 | 11 | Renin-angiotensin system |
| galcanezumab | 21 | 13 | Analgesics |
| ivosidenib | 21 | 12 | Antineoplastics |
| efgartigimod alfa | 20 | 11 | Immunosuppressants |
| fremanezumab | 20 | 13 | Analgesics |
| pirtobrutinib | 20 | 14 | Antineoplastics |
| atogepant | 19 | 13 | Analgesics |
| rimegepant | 19 | 10 | Analgesics |
| belzutifan | 18 | 13 | Antineoplastics |
| inclisiran | 18 | 11 | Lipid modifying agents |
| selumetinib | 18 | 14 | Antineoplastics |
| sotorasib | 18 | 12 | Antineoplastics |
| mavacamten | 17 | 13 | Cardiac therapy |
| teclistamab | 17 | 12 | Antineoplastics |
| avacopan | 16 | 11 | Immunosuppressants |
| brivaracetam | 16 | 7 | Antiepileptics |
| givosiran | 15 | 12 | Other alimentary tract and metabolism |
| maribavir | 15 | 14 | Antivirals |
| nirmatrelvir / ritonavir | 15 | 11 | Antivirals |
| zolbetuximab | 15 | 12 | Antineoplastics |
| delgocitinib | 14 | 12 | Other dermatologicals |
| fruquintinib | 14 | 13 | Antineoplastics |
| osilodrostat | 14 | 11 | Systemic corticosteroids |
| pemigatinib | 14 | 12 | Antineoplastics |
| sotatercept | 13 | 12 | Antihypertensives |
| danicopan | 12 | 11 | Immunosuppressants |
| deucravacitinib | 12 | 10 | Immunosuppressants |
| lenacapavir | 12 | 9 | Antivirals |
| ritlecitinib | 12 | 10 | Immunosuppressants |
| sacubitril / valsartan | 12 | 9 | Renin-angiotensin system |
| vericiguat | 12 | 8 | Cardiac therapy |
| zilucoplan | 12 | 11 | Immunosuppressants |
| andexanet alfa | 11 | 9 | Other therapeutic products |
| capivasertib | 11 | 9 | Antineoplastics |
| futibatinib | 11 | 9 | Antineoplastics |
| lurasidone | 11 | 9 | Psycholeptics |
| palopegteriparatide | 11 | 8 | Calcium homeostasis |
| mosunetuzumab | 10 | 7 | Antineoplastics |
| tarlatamab | 10 | 7 | Antineoplastics |
| remimazolam | 9 | 6 | Psycholeptics |
| depemokimab | 8 | 7 | Obstructive airway diseases |
| lecanemab | 8 | 8 | Psychoanaleptics |
| molnupiravir | 8 | 6 | Antivirals |
| vortioxetine | 8 | 6 | Psychoanaleptics |
| talquetamab | 7 | 6 | Antineoplastics |